Literature DB >> 18287177

A novel random mutagenesis approach using human mutagenic DNA polymerases to generate enzyme variant libraries.

Stéphane Emond1, Philippe Mondon, Sandra Pizzut-Serin, Laurent Douchy, Fabien Crozet, Khalil Bouayadi, Hakim Kharrat, Gabrielle Potocki-Véronèse, Pierre Monsan, Magali Remaud-Simeon.   

Abstract

The in vitro MutaGen procedure is a new random mutagenesis method based on the use of low-fidelity DNA polymerases. In the present study, this technique was applied on a 2 kb gene encoding amylosucrase, an attractive enzyme for the industrial synthesis of amylose-like polymers. Mutations were first introduced during a single replicating step performed by mutagenic polymerases pol beta and pol eta. Three large libraries (>10(5) independent clones) were generated (one with pol beta and two with pol eta). The sequence analysis of randomly chosen clones confirmed the potential of this strategy for the generation of diversity. Variants generated by pol beta were 4-7-fold less mutated than those created with pol eta, indicating that our approach enables mutation rate control following the DNA polymerase employed for mutagenesis. Moreover, pol beta and pol eta provide different and complementary mutation spectra, allowing a wider sequence space exploration than error-prone PCR protocols employing Taq polymerase. Interestingly, some of the variants generated by pol eta displayed unusual modifications, including combinations of base substitutions and codon deletions which are rarely generated using other methods. By taking advantage of the mutation bias of naturally highly error-prone DNA polymerases, MutaGen thus appears as a very useful tool for gene and protein randomisation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18287177     DOI: 10.1093/protein/gzn004

Source DB:  PubMed          Journal:  Protein Eng Des Sel        ISSN: 1741-0126            Impact factor:   1.650


  6 in total

1.  Combinatorial engineering to enhance thermostability of amylosucrase.

Authors:  Stéphane Emond; Isabelle André; Kais Jaziri; Gabrielle Potocki-Véronèse; Philippe Mondon; Khalil Bouayadi; Hakim Kharrat; Pierre Monsan; Magali Remaud-Simeon
Journal:  Protein Sci       Date:  2008-04-25       Impact factor: 6.725

2.  In vivo elimination of parental clones in general and site-directed mutagenesis.

Authors:  Erika G Holland; Felicity E Acca; Kristina M Belanger; Mary E Bylo; Brian K Kay; Michael P Weiner; Margaret M Kiss
Journal:  J Immunol Methods       Date:  2014-12-15       Impact factor: 2.303

3.  Combined glyco- and protein-Fc engineering simultaneously enhance cytotoxicity and half-life of a therapeutic antibody.

Authors:  Céline Monnet; Sylvie Jorieux; Nathalie Souyris; Ouafa Zaki; Alexandra Jacquet; Nathalie Fournier; Fabien Crozet; Christophe de Romeuf; Khalil Bouayadi; Rémi Urbain; Christian K Behrens; Philippe Mondon; Alexandre Fontayne
Journal:  MAbs       Date:  2014-01-15       Impact factor: 5.857

4.  Spiked Genes: A Method to Introduce Random Point Nucleotide Mutations Evenly throughout an Entire Gene Using a Complete Set of Spiked Oligonucleotides for the Assembly.

Authors:  Edson Cárcamo; Abigail Roldán-Salgado; Joel Osuna; Iván Bello-Sanmartin; Jorge A Yáñez; Gloria Saab-Rincón; Héctor Viadiu; Paul Gaytán
Journal:  ACS Omega       Date:  2017-07-05

5.  High Throughput Techniques for Discovering New Glycine Receptor Modulators and their Binding Sites.

Authors:  Daniel F Gilbert; Robiul Islam; Timothy Lynagh; Joseph W Lynch; Timothy I Webb
Journal:  Front Mol Neurosci       Date:  2009-10-30       Impact factor: 5.639

6.  Accessing unexplored regions of sequence space in directed enzyme evolution via insertion/deletion mutagenesis.

Authors:  Stephane Emond; Maya Petek; Emily J Kay; Brennen Heames; Sean R A Devenish; Nobuhiko Tokuriki; Florian Hollfelder
Journal:  Nat Commun       Date:  2020-07-10       Impact factor: 14.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.